Introduction
Moxifloxacin hydrochloride is a broad-spectrum fluoroquinolone antibiotic used to treat a variety of bacterial infections. It is often administered intravenously in hospital settings for more severe infections or when oral administration is not possible.
Uses
Moxifloxacin hydrochloride injection is used to treat infections caused by susceptible strains of bacteria. Indications include:
- Community-acquired pneumonia
- Complicated skin and soft tissue infections
- Complicated intra-abdominal infections
- Acute bacterial sinusitis
| Brand Name | Moxilocin |
|---|---|
| Type | IV Infusion |
| Weight | 400 mg/250 ml |
| Generic | Moxifloxacin Hydrochloride (Injection) |
| Manufacturer | Opsonin Pharma Ltd. |
| Available in | English বাংলা |
Mechanism of Action
Moxifloxacin works by inhibiting bacterial DNA gyrase and topoisomerase IV, enzymes essential for bacterial DNA replication, transcription, and repair. By blocking these enzymes, moxifloxacin prevents bacterial cell division and growth, ultimately leading to bacterial cell death.
How Long Does It Take to Work?
The onset of action for moxifloxacin can vary, but improvement in symptoms may be observed within a few days of starting treatment. The full course of therapy should be completed as prescribed to ensure complete eradication of the infection.
Absorption
When administered intravenously, moxifloxacin achieves immediate and complete bioavailability. The systemic absorption is direct, bypassing the gastrointestinal tract, which is beneficial in cases where oral administration is not feasible.
Route of Elimination
Moxifloxacin is primarily eliminated through the liver. It undergoes hepatic metabolism and is excreted in the urine and feces. A small amount is eliminated unchanged in the urine.
Dosage
The dose of Moxifloxacin is 400 mg once daily. The duration of therapy depends on the type of infection as described in following:- Acute Bacterial Sinusitis: 400 mg once daily for 10 days.
- Acute Bacterial Exacerbation of Chronic Bronchitis: 400 mg once daily for 5 days.
- Community Acquired Pneumonia: 400 mg once daily for 7-14 days.
- Uncomplicated Skin and Skin Structure Infections: 400 mg once daily for 7 days.
- Complicated Skin and Skin Structure Infections: 400 mg once daily for 7-21 days.
- Complicated Intra-Abdominal Infections: 400 mg once daily for 5-14 days.
The dosage of moxifloxacin hydrochloride injection depends on the type and severity of the infection. Typical dosages are:
- For community-acquired pneumonia and complicated skin infections: 400 mg administered intravenously once daily.
- For complicated intra-abdominal infections: 400 mg administered intravenously once daily.
Administration
Moxifloxacin hydrochloride is administered intravenously as an infusion. It should be infused slowly over 60 minutes to minimize the risk of adverse reactions. It is important to follow proper aseptic techniques during administration.
Side Effects
Common side effects of moxifloxacin injection include:
- Nausea and vomiting
- Diarrhea
- Headache
- Dizziness
- Rash
Toxicity
Toxicity can occur with overdose or prolonged use. Symptoms of toxicity may include severe gastrointestinal symptoms, CNS effects such as confusion, and cardiovascular issues. In case of overdose, supportive measures and symptomatic treatment should be employed.
Precautions
- **Tendon Damage**: Moxifloxacin has been associated with tendonitis and tendon rupture, particularly in older adults and those receiving concomitant corticosteroids. - **QT Interval Prolongation**: Use with caution in patients with a history of QT interval prolongation or who are taking other QT-prolonging drugs. - **Liver Function**: Monitor liver function tests in patients with pre-existing liver conditions.
Interaction
Moxifloxacin may interact with other medications, including:
- Anticoagulants (e.g., warfarin) which may increase bleeding risk.
- Drugs that prolong the QT interval.
Disease Interaction
Use cautiously in patients with renal impairment, liver disease, or a history of seizures. Adjustments in dosage or monitoring may be required.
Drug Interaction
Potential interactions include:
- Antacids and iron supplements may reduce moxifloxacin absorption.
- Drugs that inhibit CYP450 enzymes may increase moxifloxacin levels.
Food Interactions
There are no significant food interactions with moxifloxacin injection as it is administered intravenously. However, oral moxifloxacin should be taken with adequate hydration and away from meals containing calcium or magnesium.
Pregnancy Use
Moxifloxacin is classified as Category C for pregnancy. It should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. Consult a healthcare provider before use.
Lactation Use
Moxifloxacin is excreted in breast milk. Use with caution during lactation, and weigh the potential benefits against the risks to the infant. Consult a healthcare provider if breastfeeding.
Acute Overdose
In case of acute overdose, supportive care and symptomatic treatment are recommended. There is no specific antidote. Monitor the patient for adverse effects and provide appropriate interventions.
Contraindication
Moxifloxacin is contraindicated in individuals with a known hypersensitivity to fluoroquinolones. It should also be avoided in patients with a history of tendon disorders related to fluoroquinolone use.
Use Direction
Follow the prescribed dosage and administration guidelines. Administer the infusion slowly over 60 minutes and monitor the patient for any adverse reactions during and after infusion.
Storage Conditions
Store moxifloxacin hydrochloride injection at room temperature (20-25°C) and protect from light. Do not freeze or expose to extreme temperatures. Keep out of reach of children.
Volume of Distribution
The volume of distribution for moxifloxacin is approximately 2.2 to 2.8 L/kg, indicating good tissue penetration.
Half Life
The half-life of moxifloxacin is approximately 12 hours. This allows for once-daily dosing when administered intravenously.
Clearance
Moxifloxacin is primarily cleared by the liver with a clearance rate of approximately 2.7 L/h. Renal clearance is minimal, reflecting its predominant hepatic metabolism.
See in details version Moxilocin IV Infusion 400 mg/250 ml also Moxilocin IV Infusion 400 mg/250 ml in bangla
Social card
